收费全文 | 24664篇 |
免费 | 1669篇 |
国内免费 | 92篇 |
耳鼻咽喉 | 201篇 |
儿科学 | 875篇 |
妇产科学 | 703篇 |
基础医学 | 2989篇 |
口腔科学 | 260篇 |
临床医学 | 3944篇 |
内科学 | 4397篇 |
皮肤病学 | 296篇 |
神经病学 | 2440篇 |
特种医学 | 524篇 |
外科学 | 2043篇 |
综合类 | 279篇 |
一般理论 | 64篇 |
预防医学 | 3600篇 |
眼科学 | 331篇 |
药学 | 1467篇 |
1篇 | |
中国医学 | 26篇 |
肿瘤学 | 1985篇 |
2023年 | 88篇 |
2022年 | 69篇 |
2021年 | 368篇 |
2020年 | 291篇 |
2019年 | 457篇 |
2018年 | 548篇 |
2017年 | 428篇 |
2016年 | 434篇 |
2015年 | 498篇 |
2014年 | 778篇 |
2013年 | 1244篇 |
2012年 | 1794篇 |
2011年 | 1870篇 |
2010年 | 1026篇 |
2009年 | 895篇 |
2008年 | 1715篇 |
2007年 | 1849篇 |
2006年 | 1805篇 |
2005年 | 1844篇 |
2004年 | 1760篇 |
2003年 | 1668篇 |
2002年 | 1537篇 |
2001年 | 165篇 |
2000年 | 117篇 |
1999年 | 207篇 |
1998年 | 291篇 |
1997年 | 189篇 |
1996年 | 179篇 |
1995年 | 208篇 |
1994年 | 192篇 |
1993年 | 175篇 |
1992年 | 109篇 |
1991年 | 105篇 |
1990年 | 80篇 |
1989年 | 96篇 |
1988年 | 79篇 |
1987年 | 71篇 |
1986年 | 72篇 |
1985年 | 81篇 |
1984年 | 113篇 |
1983年 | 114篇 |
1982年 | 132篇 |
1981年 | 120篇 |
1980年 | 113篇 |
1979年 | 56篇 |
1978年 | 61篇 |
1977年 | 62篇 |
1976年 | 46篇 |
1975年 | 41篇 |
1974年 | 41篇 |
Background
Vaccination of children with 13-valent pneumococcal conjugate vaccine (PCV13) led to declines in vaccine-type pneumococcal nasopharyngeal carriage among adults through indirect effects. In August 2014, PCV13 immunization of all U.S. adults ≥65?years of age was recommended. This study sought to define prevalence and serotype distribution of pneumococcal carriage among adults ≥65?years of age and to describe risk factors for colonization soon after introduction of PCV13 in adults.Methods
A cross-sectional survey of non-institutionalized U.S. adults ≥65?years of age was conducted in four states in 2015–2016. Demographic information, risk factors for disease, PCV13 vaccination history, and nasopharyngeal (NP) and oropharyngeal (OP) swabs were collected. NP and OP swabs were processed separately and pneumococcal isolates were serotyped by Quellung reaction. Antimicrobial susceptibility of pneumococcal isolates was performed. NP swabs also underwent real-time PCR for pneumococcal detection and serotyping.Results
Of 2989 participants, 45.3% (1354/2989) had been vaccinated with PCV13. Fifty-five (1.8%) carried pneumococcus (45 identified by culture and 10 by real-time PCR only) and PCV13 serotypes were found in eight (0.3%) participants. Almost half (22/45) of pneumococcal isolates were not susceptible to at least one of the antibiotics tested. Vaccine-type carriage among vaccinated and unvaccinated individuals was similar (0.2% vs. 0.1%, respectively). Respiratory symptoms were associated with higher odds of pneumococcal colonization (adjusted OR: 2.1; 95% CI?=?1.1–3.8).Conclusions
Pneumococcal carriage among non-institutionalized adults ≥65?years of age was very low. Less than 0.5% of both vaccinated and unvaccinated individuals in our study carried vaccine-type serotypes. Over a decade of PCV vaccination of children likely led to indirect effects in adults. However, given the low vaccine-type carriage rates we observed in an already high PCV13 adult coverage setting, it is difficult to attribute our findings to the direct versus indirect effects of PCV13 on adult carriage. 相似文献Objective: We examined characteristics of caregivers and stroke survivors associated with caregivers’ depressive symptoms in the early poststroke period.
Methods: We conducted a prospective, longitudinal exploratory observational study with a convenience sample of 63 caregivers of older adult (≥ 65 years) stroke survivors recruited from urban acute-care settings. We enrolled caregivers by 2 weeks poststroke (T1) and revisited them 4 weeks later (T2). Depressive symptoms were measured using the Patient Health Questionnaire-9. A separate unadjusted linear mixed model was computed to explore significant associations between each caregiver or stroke-survivor characteristic and depressive symptoms.
Results: Caregivers, on average, reported mild depressive symptoms at T1 and T2. Each of the following characteristics was independently associated with caregiver depressive symptoms over the first 6 weeks poststroke: caregiver uncertainty (p < 0.001), perceived stress (p < 0.001) but not cortisol levels (p = 0.858 on waking, p = 0.231 evening), coping (p < 0.001), social support (p = 0.006), race (p = 0.022), income (p = 0.001), time spent on care (p = 0.039), and stroke-survivor race (p = 0.033) and functional status (p = 0.003). At T2, caregiver depressive symptoms were correlated with evening cortisol level (p = 0.001).
Conclusions: Caregiver and stroke-survivor characteristics may help identify caregivers at highest risk for early depressive symptoms and guide interventions aimed at their resolution. 相似文献